S&P 500   4,693.26 (+0.14%)
DOW   35,692.18 (-0.08%)
QQQ   398.29 (+0.12%)
AAPL   174.29 (+1.82%)
MSFT   332.37 (-0.76%)
FB   330.46 (+2.37%)
GOOGL   2,939.89 (-0.19%)
AMZN   3,522.13 (-0.03%)
TSLA   1,061.61 (+0.94%)
NVDA   318.11 (-1.90%)
BABA   126.06 (+0.41%)
NIO   35.00 (+5.68%)
CGC   11.04 (+3.76%)
AMD   144.75 (-0.07%)
GE   98.37 (+0.84%)
MU   85.83 (+0.00%)
T   23.22 (+0.61%)
F   19.84 (-0.60%)
DIS   153.51 (+1.79%)
PFE   51.47 (-0.48%)
AMC   32.69 (+5.32%)
ACB   6.65 (+4.23%)
BA   211.11 (+1.09%)
S&P 500   4,693.26 (+0.14%)
DOW   35,692.18 (-0.08%)
QQQ   398.29 (+0.12%)
AAPL   174.29 (+1.82%)
MSFT   332.37 (-0.76%)
FB   330.46 (+2.37%)
GOOGL   2,939.89 (-0.19%)
AMZN   3,522.13 (-0.03%)
TSLA   1,061.61 (+0.94%)
NVDA   318.11 (-1.90%)
BABA   126.06 (+0.41%)
NIO   35.00 (+5.68%)
CGC   11.04 (+3.76%)
AMD   144.75 (-0.07%)
GE   98.37 (+0.84%)
MU   85.83 (+0.00%)
T   23.22 (+0.61%)
F   19.84 (-0.60%)
DIS   153.51 (+1.79%)
PFE   51.47 (-0.48%)
AMC   32.69 (+5.32%)
ACB   6.65 (+4.23%)
BA   211.11 (+1.09%)
S&P 500   4,693.26 (+0.14%)
DOW   35,692.18 (-0.08%)
QQQ   398.29 (+0.12%)
AAPL   174.29 (+1.82%)
MSFT   332.37 (-0.76%)
FB   330.46 (+2.37%)
GOOGL   2,939.89 (-0.19%)
AMZN   3,522.13 (-0.03%)
TSLA   1,061.61 (+0.94%)
NVDA   318.11 (-1.90%)
BABA   126.06 (+0.41%)
NIO   35.00 (+5.68%)
CGC   11.04 (+3.76%)
AMD   144.75 (-0.07%)
GE   98.37 (+0.84%)
MU   85.83 (+0.00%)
T   23.22 (+0.61%)
F   19.84 (-0.60%)
DIS   153.51 (+1.79%)
PFE   51.47 (-0.48%)
AMC   32.69 (+5.32%)
ACB   6.65 (+4.23%)
BA   211.11 (+1.09%)
S&P 500   4,693.26 (+0.14%)
DOW   35,692.18 (-0.08%)
QQQ   398.29 (+0.12%)
AAPL   174.29 (+1.82%)
MSFT   332.37 (-0.76%)
FB   330.46 (+2.37%)
GOOGL   2,939.89 (-0.19%)
AMZN   3,522.13 (-0.03%)
TSLA   1,061.61 (+0.94%)
NVDA   318.11 (-1.90%)
BABA   126.06 (+0.41%)
NIO   35.00 (+5.68%)
CGC   11.04 (+3.76%)
AMD   144.75 (-0.07%)
GE   98.37 (+0.84%)
MU   85.83 (+0.00%)
T   23.22 (+0.61%)
F   19.84 (-0.60%)
DIS   153.51 (+1.79%)
PFE   51.47 (-0.48%)
AMC   32.69 (+5.32%)
ACB   6.65 (+4.23%)
BA   211.11 (+1.09%)
NASDAQ:VRAY

ViewRay Stock Forecast, Price & News

$5.75
+0.42 (+7.88%)
(As of 12/8/2021 02:27 PM ET)
Add
Compare
Today's Range
$5.27
$5.99
50-Day Range
$4.89
$7.59
52-Week Range
$3.79
$8.25
Volume
127,190 shs
Average Volume
1.53 million shs
Market Capitalization
$947.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.8
30 days | 90 days | 365 days | Advanced Chart
Receive VRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for ViewRay and its competitors with MarketBeat's FREE daily newsletter.


ViewRay logo

About ViewRay

ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. It develops MRIdian to address the limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that defines the tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova in 2004 and is headquartered in Oakwood Village, OH.

Headlines

ViewRay (NASDAQ:VRAY) Stock Price Up 10.1%
December 8, 2021 |  americanbankingnews.com
ViewRay (NASDAQ:VRAY) Shares Gap Up to $4.89
December 3, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VRAY
Employees
236
Year Founded
N/A

Sales & Book Value

Annual Sales
$57.02 million
Book Value
$0.71 per share

Profitability

Net Income
$-107.91 million
Net Margins
-159.97%
Pretax Margin
-159.97%

Debt

Price-To-Earnings

Miscellaneous

Free Float
156,834,000
Market Cap
$947.27 million
Optionable
Optionable

Company Calendar

Last Earnings
11/04/2021
Today
12/08/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
3/03/2022

MarketRank

Overall MarketRank

2.18 out of 5 stars

Medical Sector

404th out of 1,394 stocks

Electromedical Equipment Industry

9th out of 30 stocks

Analyst Opinion: 2.3Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -












ViewRay (NASDAQ:VRAY) Frequently Asked Questions

Is ViewRay a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ViewRay in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ViewRay stock.
View analyst ratings for ViewRay
or view top-rated stocks.

How has ViewRay's stock price been impacted by COVID-19 (Coronavirus)?

ViewRay's stock was trading at $1.69 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, VRAY stock has increased by 249.1% and is now trading at $5.90.
View which stocks have been most impacted by COVID-19
.

When is ViewRay's next earnings date?

ViewRay is scheduled to release its next quarterly earnings announcement on Thursday, March 3rd 2022.
View our earnings forecast for ViewRay
.

How were ViewRay's earnings last quarter?

ViewRay, Inc. (NASDAQ:VRAY) announced its quarterly earnings data on Thursday, November, 4th. The company reported ($0.15) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.16) by $0.01. The company had revenue of $19.18 million for the quarter, compared to analysts' expectations of $17.05 million. ViewRay had a negative net margin of 159.97% and a negative trailing twelve-month return on equity of 79.12%. The company's quarterly revenue was up 90.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.19) earnings per share.
View ViewRay's earnings history
.

What guidance has ViewRay issued on next quarter's earnings?

ViewRay updated its FY 2021 earnings guidance on Thursday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $63 million-$73 million, compared to the consensus revenue estimate of $68.90 million.

What price target have analysts set for VRAY?

5 equities research analysts have issued 12 month target prices for ViewRay's shares. Their forecasts range from $3.00 to $9.00. On average, they anticipate ViewRay's stock price to reach $6.50 in the next twelve months. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for ViewRay
or view top-rated stocks among Wall Street analysts.

Who are ViewRay's key executives?

ViewRay's management team includes the following people:
  • Scott William Drake, President, Chief Executive Officer & Director (LinkedIn Profile)
  • Zachary Stassen, Chief Financial Officer
  • James F. Dempsey, Chief Scientific Officer
  • Martin Fuss, Chief Medical Officer
  • Robert S. McCormack, Secretary, Senior VP & General Counsel

What is Scott Drake's approval rating as ViewRay's CEO?

5 employees have rated ViewRay CEO Scott Drake on Glassdoor.com. Scott Drake has an approval rating of 59% among ViewRay's employees. This puts Scott Drake in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of ViewRay own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ViewRay investors own include Alibaba Group (BABA), Amarin (AMRN), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Verastem (VSTM), Corbus Pharmaceuticals (CRBP), Viking Therapeutics (VKTX), AbbVie (ABBV), Accuray (ARAY) and Selecta Biosciences (SELB).

When did ViewRay IPO?

(VRAY) raised $52 million in an IPO on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel acted as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

What is ViewRay's stock symbol?

ViewRay trades on the NASDAQ under the ticker symbol "VRAY."

Who are ViewRay's major shareholders?

ViewRay's stock is owned by many different retail and institutional investors. Top institutional investors include Artisan Partners Limited Partnership (14.77%), BlackRock Inc. (5.91%), Bamco Inc. NY (2.67%), Geode Capital Management LLC (1.37%), Millennium Management LLC (1.17%) and Dimensional Fund Advisors LP (1.02%). Company insiders that own ViewRay stock include Influence Ltd Strong, International Ltd Fosun, Scott William Drake and Zachary William Stassen.
View institutional ownership trends for ViewRay
.

Which institutional investors are selling ViewRay stock?

VRAY stock was sold by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Barclays PLC, Morgan Stanley, Panagora Asset Management Inc., Deutsche Bank AG, Caption Management LLC, Goldman Sachs Group Inc., and Telemetry Investments L.L.C.. Company insiders that have sold ViewRay company stock in the last year include Influence Ltd Strong, and International Ltd Fosun.
View insider buying and selling activity for ViewRay
or view top insider-selling stocks.

Which institutional investors are buying ViewRay stock?

VRAY stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Artisan Partners Limited Partnership, Invesco Ltd., Bamco Inc. NY, Dimensional Fund Advisors LP, Marshall Wace LLP, BlackRock Inc., and Royal Bank of Canada. Company insiders that have bought ViewRay stock in the last two years include Scott William Drake, and Zachary William Stassen.
View insider buying and selling activity for ViewRay
or or view top insider-buying stocks.

How do I buy shares of ViewRay?

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ViewRay's stock price today?

One share of VRAY stock can currently be purchased for approximately $5.90.

How much money does ViewRay make?

ViewRay has a market capitalization of $971.98 million and generates $57.02 million in revenue each year. The company earns $-107.91 million in net income (profit) each year or ($0.69) on an earnings per share basis.

How many employees does ViewRay have?

ViewRay employs 236 workers across the globe.

What is ViewRay's official website?

The official website for ViewRay is www.viewray.com.

Where are ViewRay's headquarters?

ViewRay is headquartered at 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146.

How can I contact ViewRay?

ViewRay's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at (440) 703-3210, via email at [email protected], or via fax at 800-417-3459.


This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.